NO911200L - Fremgangsmaate for fremstilling av selektive adenosin-receptor midler. - Google Patents

Fremgangsmaate for fremstilling av selektive adenosin-receptor midler.

Info

Publication number: NO911200L
Authority: NO; Norway
Prior art keywords: selective; procedure; preparation; receptor agents; adenosin
Prior art date: 1990-03-26

Application number

NO91911200A

Other languages

English (en)

Other versions

NO911200D0 (no

NO177591B (no

NO177591C (no

Inventor

Norton Paul Peet

Nelson Lowell Lentz

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-03-26

Filing date

1991-03-25

Publication date

1991-09-27

1991-03-25 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1991-03-25 Publication of NO911200D0 publication Critical patent/NO911200D0/no

1991-09-27 Publication of NO911200L publication Critical patent/NO911200L/no

1995-07-10 Publication of NO177591B publication Critical patent/NO177591B/no

1995-10-18 Publication of NO177591C publication Critical patent/NO177591C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO911200A 1990-03-26 1991-03-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler NO177591C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/499,111 US5047534A (en)	1990-03-26	1990-03-26	Selective adenosine receptor agents

Publications (4)

Publication Number	Publication Date
NO911200D0 NO911200D0 (no)	1991-03-25
NO911200L true NO911200L (no)	1991-09-27
NO177591B NO177591B (no)	1995-07-10
NO177591C NO177591C (no)	1995-10-18

Family

ID=23983864

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO911200A NO177591C (no)	1990-03-26	1991-03-25	Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler

Country Status (22)

Country	Link
US (1)	US5047534A (no)
EP (1)	EP0449175B1 (no)
JP (1)	JP3181305B2 (no)
KR (1)	KR100195368B1 (no)
CN (1)	CN1032815C (no)
AR (1)	AR247887A1 (no)
AT (1)	ATE156130T1 (no)
AU (1)	AU632914B2 (no)
CA (1)	CA2038747C (no)
DE (1)	DE69127010T2 (no)
DK (1)	DK0449175T3 (no)
ES (1)	ES2107431T3 (no)
FI (1)	FI98461C (no)
GR (1)	GR3025135T3 (no)
HU (1)	HU208824B (no)
IE (1)	IE910982A1 (no)
IL (1)	IL97656A (no)
NO (1)	NO177591C (no)
NZ (1)	NZ237484A (no)
PH (1)	PH27511A (no)
PT (1)	PT97133B (no)
ZA (1)	ZA912038B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5208240A (en) *	1991-03-12	1993-05-04	Merrell Dow Pharmaceuticals Inc.	8-substituted purines as selective adenosine receptor agents
DK0628311T3 (da) *	1992-07-08	2002-07-22	Kyowa Hakko Kogyo Kk	Xanthinderivater som antidepressive midler
CA2155130C (en) *	1993-02-26	1994-09-01	Janice M Hitchcock	Xanthine derivatives as adenosine a1 receptor antagonists
AU6781194A (en) *	1993-05-03	1994-11-21	United States Of America, Represented By The Secretary, Department Of Health And Human Services, The	8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
JPH08509977A (ja) *	1993-05-06	1996-10-22	メレルダウファーマスーティカルズインコーポレイテッド	選択的アデノシン受容体剤としての８−置換キサンチン類
US5629298A (en) *	1995-03-13	1997-05-13	University Of Massachusetts Medical Center	Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en) *	1998-09-04	1998-10-28	Cerebrus Ltd	Chemical compounds I
US6258794B1 (en)	1999-12-14	2001-07-10	The Mclean Hospital Corporation	Treatment of mental conditions including depression
JP4778894B2 (ja)	2003-06-10	2011-09-21	協和発酵キリン株式会社	不安障害の治療方法
WO2007036491A1 (de) *	2005-09-30	2007-04-05	Basf Aktiengesellschaft	Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) *	2005-12-21	2009-09-22	Bristol-Myers Squibb Company	Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
KR102060903B1 (ko) *	2018-09-12	2019-12-30	김지훈	다중접합 도마 및 그 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1435916A (en) *	1972-05-11	1976-05-19	Beecham Group Ltd	Pharmaceutical weight-reducing compositions
SE416810C (sv) *	1977-10-14	1982-07-19	Draco Ab	Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) *	1981-05-28	1982-12-06	Sony Corp	Manufacture of magnetic recording medium
US4593095A (en) *	1983-02-18	1986-06-03	The Johns Hopkins University	Xanthine derivatives
US4772607A (en) *	1986-05-20	1988-09-20	Warner-Lambert Company	Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) *	1986-11-13	1988-11-08	Marion Laboratories, Inc.	8-arylxanthines
DE8817122U1 (de) *	1988-12-22	1993-02-04	Boehringer Ingelheim Kg, 55218 Ingelheim	Neue Xanthinderivate mit Adenosinantogenistischer Wirkung

1990
- 1990-03-26 US US07/499,111 patent/US5047534A/en not_active Expired - Fee Related
1991
- 1991-03-19 AU AU73537/91A patent/AU632914B2/en not_active Ceased
- 1991-03-19 NZ NZ237484A patent/NZ237484A/xx unknown
- 1991-03-19 ZA ZA912038A patent/ZA912038B/xx unknown
- 1991-03-20 AR AR91319262A patent/AR247887A1/es active
- 1991-03-21 CA CA002038747A patent/CA2038747C/en not_active Expired - Fee Related
- 1991-03-22 PH PH42193A patent/PH27511A/en unknown
- 1991-03-22 IL IL9765691A patent/IL97656A/en not_active IP Right Cessation
- 1991-03-25 CN CN91101892A patent/CN1032815C/zh not_active Expired - Fee Related
- 1991-03-25 FI FI911420A patent/FI98461C/fi active
- 1991-03-25 PT PT97133A patent/PT97133B/pt not_active IP Right Cessation
- 1991-03-25 DE DE69127010T patent/DE69127010T2/de not_active Expired - Fee Related
- 1991-03-25 HU HU91985A patent/HU208824B/hu not_active IP Right Cessation
- 1991-03-25 ES ES91104668T patent/ES2107431T3/es not_active Expired - Lifetime
- 1991-03-25 AT AT91104668T patent/ATE156130T1/de not_active IP Right Cessation
- 1991-03-25 EP EP91104668A patent/EP0449175B1/en not_active Expired - Lifetime
- 1991-03-25 DK DK91104668.8T patent/DK0449175T3/da active
- 1991-03-25 IE IE098291A patent/IE910982A1/en not_active IP Right Cessation
- 1991-03-25 KR KR1019910004660A patent/KR100195368B1/ko not_active IP Right Cessation
- 1991-03-25 NO NO911200A patent/NO177591C/no not_active IP Right Cessation
- 1991-03-26 JP JP08451291A patent/JP3181305B2/ja not_active Expired - Fee Related
1997
- 1997-10-22 GR GR970402767T patent/GR3025135T3/el unknown

Also Published As

Publication number	Publication date
NO911200D0 (no)	1991-03-25
IL97656A (en)	1996-06-18
JPH04221384A (ja)	1992-08-11
DE69127010T2 (de)	1997-11-13
CN1055181A (zh)	1991-10-09
FI98461B (fi)	1997-03-14
HU208824B (en)	1994-01-28
AU7353791A (en)	1991-10-03
ES2107431T3 (es)	1997-12-01
ZA912038B (en)	1991-12-24
FI911420A0 (fi)	1991-03-25
CA2038747A1 (en)	1991-09-27
FI911420A (fi)	1991-09-27
NZ237484A (en)	1993-10-26
GR3025135T3 (en)	1998-02-27
NO177591B (no)	1995-07-10
FI98461C (fi)	1997-06-25
EP0449175A3 (en)	1993-01-20
CN1032815C (zh)	1996-09-18
PT97133A (pt)	1991-12-31
PT97133B (pt)	1998-07-31
IE910982A1 (en)	1991-10-09
US5047534A (en)	1991-09-10
KR910016752A (ko)	1991-11-05
EP0449175A2 (en)	1991-10-02
AU632914B2 (en)	1993-01-14
CA2038747C (en)	2002-05-28
ATE156130T1 (de)	1997-08-15
DE69127010D1 (de)	1997-09-04
KR100195368B1 (ko)	1999-06-15
DK0449175T3 (da)	1998-02-23
IL97656A0 (en)	1992-06-21
JP3181305B2 (ja)	2001-07-03
AR247887A1 (es)	1995-04-28
PH27511A (en)	1993-08-18
HUT56570A (en)	1991-09-30
EP0449175B1 (en)	1997-07-30
NO177591C (no)	1995-10-18

Legal Events

Date	Code	Title	Description
2003-10-27	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN SEPTEMBER 2003

Publication	Publication Date	Title
NO913234L (no)	1992-02-21	Fremgangsmaate for fremstilling av pyrazolderivater.
NO911139L (no)	1991-09-24	Fremgangsmaate for fremstilling av lavere olefiner.
NO912346L (no)	1991-12-19	Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO911122D0 (no)	1991-03-20	Fremgangsmaate for fremstilling av antihyperkolesterolemiske midler.
NO902003D0 (no)	1990-05-07	Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO885454L (no)	1990-06-11	Fremgangsmaate for fremstilling av triklormonosilan.
NO901554D0 (no)	1990-04-05	Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO911200L (no)	1991-09-27	Fremgangsmaate for fremstilling av selektive adenosin-receptor midler.
NO894210D0 (no)	1989-10-23	Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO894649D0 (no)	1989-11-22	Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO895032D0 (no)	1989-12-14	Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO903043L (no)	1991-01-08	Fremgangsmaate for fremstilling av kromanderivater.
NO890159D0 (no)	1989-01-13	Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO901424D0 (no)	1990-03-28	Fremgangsmaate for fremstilling av selektive adenosinreseptorforbindelser.
NO901067D0 (no)	1990-03-07	Fremgangsmaate for fremstilling av tiofener.
NO902762D0 (no)	1990-06-21	Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO895040D0 (no)	1989-12-14	Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO900969L (no)	1990-09-04	Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO911672L (no)	1991-10-28	Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO892468D0 (no)	1989-06-14	Fremgangsmaate for fremstilling av polyuretanskum.
NO880127L (no)	1988-07-15	Fremgangsmaate for fremstilling av (+-)-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylater.
NO902363L (no)	1991-12-02	Fremgangsmaate for fremstilling av laktulose.
NO904070D0 (no)	1990-09-18	Fremgangsmaate for fremstilling av alkanfenoner.
NO913429D0 (no)	1991-09-02	Fremgangsmaate for fremstilling av 5-benzyl-substituerte benzimidazolin-2-tion-derivater.
NO890819D0 (no)	1989-02-27	Fremgangsmaate for fremstilling av hydroksybenzaldehyder.